127 related articles for article (PubMed ID: 27499236)
1. Organ-specific radiation-induced cancer risk estimates due to radiotherapy for benign pigmented villonodular synovitis.
Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
Phys Med Biol; 2016 Sep; 61(17):6400-12. PubMed ID: 27499236
[TBL] [Abstract][Full Text] [Related]
2. Radiation dose and cancer risk to out-of-field and partially in-field organs from radiotherapy for symptomatic vertebral hemangiomas.
Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
Med Phys; 2016 Apr; 43(4):1841. PubMed ID: 27036581
[TBL] [Abstract][Full Text] [Related]
3. Risk of developing radiogenic cancer following photon-beam radiotherapy for Graves' orbitopathy.
Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
Med Phys; 2018 Oct; 45(10):4775-4782. PubMed ID: 30105825
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy for non-malignant shoulder syndrome: Is there a risk for radiation-induced carcinogenesis?
Mazonakis M; Lyraraki E; Tzedakis A; Damilakis J
Phys Med; 2017 Nov; 43():73-78. PubMed ID: 29195566
[TBL] [Abstract][Full Text] [Related]
5. Cancer risk estimates from radiation therapy for heterotopic ossification prophylaxis after total hip arthroplasty.
Mazonakis M; Berris T; Lyraraki E; Damilakis J
Med Phys; 2013 Oct; 40(10):101702. PubMed ID: 24089892
[TBL] [Abstract][Full Text] [Related]
6. Out-of-field organ doses and associated radiogenic risks from para-aortic radiotherapy for testicular seminoma.
Mazonakis M; Berris T; Varveris C; Lyraraki E; Damilakis J
Med Phys; 2014 May; 41(5):051702. PubMed ID: 24784368
[TBL] [Abstract][Full Text] [Related]
7. Secondary cancer-incidence risk estimates for external radiotherapy and high-dose-rate brachytherapy in cervical cancer: phantom study.
Lee B; Ahn SH; Kim H; Son J; Sung J; Han Y; Huh SJ; Kim JS; Kim DW; Yoon M
J Appl Clin Med Phys; 2016 Sep; 17(5):124-132. PubMed ID: 27685104
[TBL] [Abstract][Full Text] [Related]
8. Monte Carlo study of organ doses and related risk for cancer in Algeria from scattered neutrons in prostate treatment involving 3D-CRT.
Alem-Bezoubiri A; Suleiman SA; Behidj I; Mazrou H; Chami AC
Appl Radiat Isot; 2022 Feb; 180():110065. PubMed ID: 34933226
[TBL] [Abstract][Full Text] [Related]
9. Combined partial arthroscopic synovectomy and radiation therapy for diffuse pigmented villonodular synovitis of the knee.
Blanco CE; Leon HO; Guthrie TB
Arthroscopy; 2001 May; 17(5):527-31. PubMed ID: 11337722
[TBL] [Abstract][Full Text] [Related]
10. Pigmented villonodular synovitis (PVNS) of the knee joint: magnetic resonance imaging (MRI) using standard and dynamic paramagnetic contrast media. Report of 52 cases surgically and histologically controlled.
Barile A; Sabatini M; Iannessi F; Di Cesare E; Splendiani A; Calvisi V; Masciocchi C
Radiol Med; 2004 Apr; 107(4):356-66. PubMed ID: 15103287
[TBL] [Abstract][Full Text] [Related]
11. MONTE CARLO SIMULATION OF OUT-OF-FIELD ORGAN DOSES AND CANCER RISK IN TANZANIA FOR RADIATION THERAPY OF UNILATERAL RETINOBLASTOMA USING A 60Co UNIT.
Suleiman SA; Qi Y; Pi Y; George Xu X
Radiat Prot Dosimetry; 2018 May; 179(3):263-270. PubMed ID: 29216393
[TBL] [Abstract][Full Text] [Related]
12. Low-dose external beam radiotherapy as a postoperative treatment for patients with diffuse pigmented villonodular synovitis of the knee: 4 recurrences in 23 patients followed for mean 9 years.
Park G; Kim YS; Kim JH; Lee SW; Song SY; Choi EK; Yi SY; Ahn SD
Acta Orthop; 2012 Jun; 83(3):256-60. PubMed ID: 22489888
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy for stage I seminoma of the testis: Organ equivalent dose to partially in-field structures and second cancer risk estimates on the basis of a mechanistic, bell-shaped, and plateau model.
Mazonakis M; Varveris C; Lyraraki E; Damilakis J
Med Phys; 2015 Nov; 42(11):6309-16. PubMed ID: 26520723
[TBL] [Abstract][Full Text] [Related]
14. [Combined treatment of the diffuse form of pigmented villonodular synovitis].
Ustinova VF; Podliashuk EL; Rodionova SS
Med Radiol (Mosk); 1986 Mar; 31(3):27-31. PubMed ID: 3959795
[TBL] [Abstract][Full Text] [Related]
15. External beam radiation therapy enhances local control in pigmented villonodular synovitis.
Horoschak M; Tran PT; Bachireddy P; West RB; Mohler D; Beaulieu CF; Kapp DS; Donaldson SS
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):183-7. PubMed ID: 19211195
[TBL] [Abstract][Full Text] [Related]
16. Second cancer risk assessments after involved-site radiotherapy for mediastinal Hodgkin lymphoma.
Mazonakis M; Lyraraki E; Damilakis J
Med Phys; 2017 Jul; 44(7):3866-3874. PubMed ID: 28493609
[TBL] [Abstract][Full Text] [Related]
17. Peripheral organ doses from radiotherapy for heterotopic ossification of non-hip joints: is there a risk for radiation-induced malignancies?
Berris T; Mazonakis M; Kachris S; Damilakis J
Phys Med; 2014 May; 30(3):309-13. PubMed ID: 24084192
[TBL] [Abstract][Full Text] [Related]
18. Radiation therapy for stage IIA and IIB testicular seminoma: peripheral dose calculations and risk assessments.
Mazonakis M; Berris T; Lyraraki E; Damilakis J
Phys Med Biol; 2015 Mar; 60(6):2375-89. PubMed ID: 25716274
[TBL] [Abstract][Full Text] [Related]
19. Pigmented villonodular synovitis.
Mendenhall WM; Mendenhall CM; Reith JD; Scarborough MT; Gibbs CP; Mendenhall NP
Am J Clin Oncol; 2006 Dec; 29(6):548-50. PubMed ID: 17148989
[TBL] [Abstract][Full Text] [Related]
20. [Effectiveness of arthroscopy and/or arthrotomy therapy for diffuse pigmented villonodular synovitis of the knee].
Liu D; Li Q; Jiang X; Tang X; Li J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2012 May; 26(5):518-21. PubMed ID: 22702040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
